Miguel Bernardo
Bernardo Arroyo, Miquel
Bernardo i Arroyo, Miquel
Bernardo, Miquel
VIAF ID: 30902424 (Personal)
Permalink: http://viaf.org/viaf/30902424
Preferred Forms
-
- 100 1 _ ‡a Bernardo i Arroyo, Miquel
- 100 1 0 ‡a Bernardo i Arroyo, Miquel
- 100 1 _ ‡a Bernardo, Miquel
-
- 100 0 _ ‡a Miguel Bernardo
4xx's: Alternate Name Forms (14)
Works
Title | Sources |
---|---|
Actividad cerebral medida con SPECT de perfusión en la esquizofrenia aguda | |
Alucinaciones auditivas en la esquizofrenia : estudio del metabolismo cerebral mediante PET con F18-FDG durante el primer episodio psicótico, tras remisión clínica y tras estimulación auditivo-lingüística | |
Casos clínicos sobre esquizofrenia 2013 | |
Cómo afrontar la esquizofrenia : una guía para familiares, cuidadores y personas afectadas | |
Consenso español sobre la terapia electroconvulsiva TEC | |
Diez años de historia de la risperidona | |
Diferencias en la respuesta a pruebas de reconocimiento facial de las emociones entre pacientes esquizofrénicos deficitarios versus esquizofrénicos no deficitarios | |
DSM-5 ¿quo vadis? | |
La esquizofrenia guia interactiva para pacientes con enfermedades de larga duración | |
Estudi de les determinacions d'àcid homavanílic en plasma i proves atencionals com a factors pronòstic a l'esquizofrènia | |
Estudi longitudinal d'efectivitat i seguretat en una cohort de malalts amb trastorn psicòtic tractats a una clinica de clozapina | |
Fenotipo y genotipo de los síntomas negativos en la esquizofrenia: Conceptualización, evaluación y su relación con el polimorfismo Val66Met del BDNF | |
Frecuencia y factores de riesgo de enfermedad cerebrovascular en esquizofrenia y trastornos relacionados | |
Guía clínica para el tratamiento de la esquizofrenia | |
Guía de buena práctica clínica en depresión y ansiedad | |
Guía de intervenciones psicológicas en la esquizofrenia | |
Hacia un perfil de riesgo psicosocial en la coronariopatía análisis de los componentes tóxicos del patrón de conducta tipo A | |
Història de la psiquiatria a Catalunya | |
Interindividual variability of brain activity in schizophrenia | |
[The management and treatment of severe mental disorders in pregnancy] | |
Las necesidades de las personas con esquizofrenia que viven en la comunidad | |
Neural bases of auditory hallucinations in schizophrenia | |
Neurocognición y biomarcadores inflamatorios en primeros episodios psicóticos | |
Neuroimagen en psiquiatría | |
Neuroinflammation in first episodes of psychosis | |
Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia. | |
Neuroleptic Treatment Effect on Mitochondrial Electron Transport Chain | |
[Neuropsychological alteration in schizophrenia and its modification] | |
Nuevos planteamientos clínicos en esquizofrenia y otros trastornos mentales graves : salud física | |
Obstetric Phenotypes in the Heterogeneity of Schizophrenia | |
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History | |
Oxcarbazepine in the treatment of bipolar and schizoaffective disorders | |
Paracingulate sulcus morphology in men with early-onset schizophrenia. | |
Pattern of electroconvulsive therapy use in Spain: Proposals for an optimal practice and equitable access | |
Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. | |
Plasma homovanillic acid in adolescents with bulimia nervosa | |
Positive versus negative symptoms in schizophrenia: Response to haloperidol | |
Practice guideline for the treatment of patients with schizophrenia | |
Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study | |
Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study | |
Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. | |
Protocolos de terapéutica psiquiátrica : versión: mayo-95 | |
¿Qué hemos aprendido de la investigación en primeros episodios psicóticos? | |
Recomendaciones prácticas en trastorno bipolar | |
[Redefining schizophrenia] | |
Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study. | |
Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia | |
Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers | |
[Repeated transcranial magnetic stimulation in children and adolescents] | |
[Reproductive variables and gynaecological service use in delusional disorder outpatients]. | |
La reserva cognitiva en el trastorno mental grave | |
The Royal College of Psychiatrists : current reviews | |
The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients. | |
The search for new biomarkers for cognition in schizophrenia | |
Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial. | |
[Selective alteration of the declarative memory systems in patients treated with a high number of electroconvulsive therapy sessions] | |
Shaped before birth: Obstetric complications identify a more severe clinical phenotype among patients presenting a first affective or non-affective episode of psychosis | |
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. | |
Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls. | |
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study. | |
[Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone] | |
Suicidal ideation, psychiatric disorder, and medical illness in a community epidemiological study. | |
Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. | |
[Systematic review of the Genomewide Association Studies (GWAS) in schizophrenia]. | |
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. | |
Terapia combinada con antidepresivos | |
Therapeutic approach to delusional disorder based on psychopathological complexity: proposal for a decision model. | |
Thinking About Electroconvulsive Therapy: The Opinions of Parents of Adolescents with Schizophrenia Spectrum Disorders | |
Transportador de la dopamina (DAT) y pronóstico de la esquizofrenia : estudio prospectivo de una cohorte evaluado mediante datscan, RM volumétrica y el polimorfismo -67 A/T del gen del dat | |
Trastornos de la personalidad : evaluación y tratamiento, perspectiva psicobiológica | |
Trastornos depresivos en patologías médicas | |
Tratamiento electroconvulsivo en niños y adolescentes | |
Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study. | |
Uso de psicofármacos en atención primaria | |
Validation of the Spanish version of the Clinical Assessment for Negative Symptoms | |
When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain | |
Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders. | |
Zer dakigu eskizofreniari buruz? : gaixo eta ahaideentzako gida |